Financial Statements · Financial Reporting
TRIZLEX BIOPHARMA OÜ
Official identifier 11220756Record date 31 Dec 2023
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 1 Jan 2023
- Submitted date
- 4 Jul 2024
Report
- Consolidated
- No
- Audited
- No
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 606,395 |
| Balance sheet | Cash and cash equivalents | 38,551 |
| Balance sheet | Current assets | 199,395 |
| Balance sheet | Current liabilities | 0 |
| Balance sheet | Equity | 470,895 |
| Balance sheet | Share capital at nominal value | 2,556 |
| Balance sheet | Non-current assets | 407,000 |
| Balance sheet | Non-current liabilities | 135,500 |
| Balance sheet | Retained earnings (loss) from previous periods | 144,490 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | 0 |
| Income statement scheme 1 | Labour costs | -21,216 |
| Income statement scheme 1 | Revenue | 744,425 |
| Income statement scheme 1 | Annual period profit / loss | 323,849 |
| Income statement scheme 1 | Operating profit (loss) | 323,849 |
| Income statement scheme 1 | Profit (loss) before income tax | 323,849 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 144,490 |
| Note: Labour costs | Employees | 2 |
| Note: Labour costs | Labour costs | 22,423 |
Linked company
Company: TRIZLEX BIOPHARMA OÜ